Clinical Scorecard: Metabolic Acidosis Care Limited in Chronic Kidney Disease

At a Glance

Key Highlights

• Only 9% of patients with metabolic acidosis received a formal diagnosis (diagnosis rates: 5% in G3a, 7% in G3b, 14% in G4).
• Treatment rates for metabolic acidosis were low: 8% overall (treatment rates: 4% in G3a, 5% in G3b, 13% in G4).

Guideline-Based Recommendations

Diagnosis

Management

• Improve clinical management practices for diagnosing and treating metabolic acidosis, including dietary interventions.

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Adults with chronic kidney disease stages G3a, G3b, and G4.

Patients with metabolic acidosis often receive renin–angiotensin system inhibitors, diuretics, and statins.

Clinical Best Practices

• Enhance the assessment and management of metabolic acidosis in CKD, noting the study's limitations regarding pH and anion gap measurements.

References

• Scientific Reports